Gemignani F - Search Results

1

Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.

De Santi C, Pucci P, Bonotti A, Melaiu O, Cipollini M, Silvestri R, Vymetalkova V, Barone E, Paolicchi E, Corrado A, Lepori I, Dell'Anno I, Pellè L, Vodicka P, Mutti L, Foddis R, Cristaudo A, Gemignani F, Landi S. De Santi C, et al. Among authors: gemignani f. Occup Environ Med. 2017 Jun;74(6):456-463. doi: 10.1136/oemed-2016-104024. Epub 2017 Mar 25. Occup Environ Med. 2017. PMID: 28343162 Free article.

2

Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein.

Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Landi D, Gemignani F, Landi S. Cristaudo A, et al. Among authors: gemignani f. Occup Environ Med. 2010 Apr;67(4):233-6. doi: 10.1136/oem.2009.049205. Epub 2009 Oct 26. Occup Environ Med. 2010. PMID: 19858537

3

Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels.

Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Gemignani F, Landi S. Cristaudo A, et al. Among authors: gemignani f. Int J Biol Markers. 2011 Apr-Jun;26(2):117-23. doi: 10.5301/JBM.2011.8332. Int J Biol Markers. 2011. PMID: 21574151 Free article.

4

A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people.

Garritano S, De Santi C, Silvestri R, Melaiu O, Cipollini M, Barone E, Lucchi M, Barale R, Mutti L, Gemignani F, Bonotti A, Foddis R, Cristaudo A, Landi S. Garritano S, et al. Among authors: gemignani f. J Thorac Oncol. 2014 Nov;9(11):1662-8. doi: 10.1097/JTO.0000000000000322. J Thorac Oncol. 2014. PMID: 25436799 Free article.

5

Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide.

Silvestri R, Pucci P, De Santi C, Dell'Anno I, Miglietta S, Corrado A, Nicolí V, Marolda D, Cipollini M, Pellegrino E, Evangelista M, Bonotti A, Foddis R, Cristaudo A, Landi S, Gemignani F. Silvestri R, et al. Among authors: gemignani f. Front Genet. 2020 Aug 18;11:975. doi: 10.3389/fgene.2020.00975. eCollection 2020. Front Genet. 2020. PMID: 33014022 Free PMC article.

6

Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism.

Gemignani F, Neri M, Bottari F, Barale R, Canessa PA, Canzian F, Ceppi M, Spitaleri I, Cipollini M, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Ugolini D, Mutti L, Bonassi S, Landi S. Gemignani F, et al. Mutat Res. 2009 Dec 1;671(1-2):76-83. doi: 10.1016/j.mrfmmm.2009.09.003. Epub 2009 Sep 12. Mutat Res. 2009. PMID: 19751749

7

Role of variations within microRNA-binding sites in cancer.

Landi D, Gemignani F, Landi S. Landi D, et al. Among authors: gemignani f. Mutagenesis. 2012 Mar;27(2):205-10. doi: 10.1093/mutage/ger055. Mutagenesis. 2012. PMID: 22294768

8

TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations.

Cipollini M, Pastor S, Gemignani F, Castell J, Garritano S, Bonotti A, Biarnés J, Figlioli G, Romei C, Marcos R, Cristaudo A, Elisei R, Landi S, Velázquez A. Cipollini M, et al. Among authors: gemignani f. Int J Cancer. 2013 Dec 15;133(12):2843-51. doi: 10.1002/ijc.28317. Epub 2013 Jul 13. Int J Cancer. 2013. PMID: 23754668

9

MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.

Melaiu O, Stebbing J, Lombardo Y, Bracci E, Uehara N, Bonotti A, Cristaudo A, Foddis R, Mutti L, Barale R, Gemignani F, Giamas G, Landi S. Melaiu O, et al. Among authors: gemignani f. PLoS One. 2014 Jan 21;9(1):e85935. doi: 10.1371/journal.pone.0085935. eCollection 2014. PLoS One. 2014. PMID: 24465798 Free PMC article.

10

MicroRNA binding site polymorphisms as biomarkers in cancer management and research.

Cipollini M, Landi S, Gemignani F. Cipollini M, et al. Among authors: gemignani f. Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014. Pharmgenomics Pers Med. 2014. PMID: 25114582 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters